CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 128 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.74 and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,576,471 | $43,106,000 | 1.62% |
| Altium Capital Management LP | 483,041 | $3,734,000 | 1.04% |
| RA Capital Management | 3,500,000 | $27,055,000 | 0.41% |
| Point72 Asset Management, L.P. | 6,335,000 | $48,970,000 | 0.23% |
| Perceptive Advisors | 2,153,974 | $16,650,000 | 0.21% |
| RTW INVESTMENTS, LP | 1,533,758 | $11,856,000 | 0.18% |
| GLOBEFLEX CAPITAL L P | 115,647 | $894,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 785,899 | $6,075,000 | 0.14% |
| Affinity Asset Advisors, LLC | 50,000 | $387,000 | 0.13% |
| Virtus ETF Advisers LLC | 38,021 | $294,000 | 0.12% |